JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB318916

Alexa Fluor® 555 Anti-CYP11A1 抗体 [EPR24868-86]

Alexa Fluor® 555 Anti-CYP11A1 antibody [EPR24868-86]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal CYP11A1 antibody - conjugated to Alexa Fluor® 555.

別名を表示する

CYP11A, CYP11A1, CYPXIA1, Cholesterol desmolase, Cytochrome P450 11A1, Cytochrome P450(scc)

関連する標識済み抗体及び組成の異なる製品 (8)

  • Unconjugated

    Anti-CYP11A1 antibody [EPR24868-86]

  • Carrier free

    Anti-CYP11A1 antibody [EPR24868-86] - BSA and Azide free

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-CYP11A1 antibody [EPR24868-86]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CYP11A1 antibody [EPR24868-86]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CYP11A1 antibody [EPR24868-86]

  • 660 APC

    APC Anti-CYP11A1 antibody [EPR24868-86]

  • 578 PE

    PE Anti-CYP11A1 antibody [EPR24868-86]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CYP11A1 antibody [EPR24868-86]

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR24868-86

アイソタイプ

IgG

標識

Alexa Fluor® 555

励起波長/蛍光波長

Ex: 555nm, Em: 565nm

キャリアフリー

No

アプリケーション

Target Binding Affinity, Antibody Labelling

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

ICC application does not react with Mouse and Rat species. Flow Cyt application does not react with Mouse species.

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@thermofisher.com.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle|Store in the dark

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CYP11A1 also called cytochrome P450scc is an important enzyme that catalyzes the first step in steroid hormone biosynthesis. This enzyme has a molecular weight of approximately 60 kDa. It is primarily located in the mitochondria of steroidogenic tissues such as the adrenal cortex testes and ovaries. CYP11A1 converts cholesterol into pregnenolone a precursor for all steroid hormones. Its gene expression is tightly regulated by trophic hormones which play an important role in modulating steroid production.
Biological function summary

CYP11A1 is a member of the cytochrome P450 superfamily a large group of enzymes known for their role in oxidation and metabolism. It exists in the mitochondrial electron transport chain working closely with proteins such as ferredoxin and ferredoxin reductase. These interactions facilitate the conversion of cholesterol to pregnenolone. Through these biochemical activities CYP11A1 controls the synthesis rate of steroid hormones influencing various physiological functions including metabolism immune response and reproductive system dynamics.

Pathways

CYP11A1 operates within the steroidogenesis pathway which is essential for the synthesis of steroid hormones like cortisol and aldosterone. It directly interacts with StAR protein which transports cholesterol into mitochondria initiating the steroidogenesis process. Moreover CYP11A1 fits into the pregnenolone biosynthesis pathway showing functional connectivity with other cytochrome P450 enzymes like CYP17A1. These interconnected pathways highlight the role of CYP11A1 as a vital catalyst in hormone synthesis affecting both endocrine and metabolic pathways.

CYP11A1 mutations or expression abnormalities have associations with conditions such as congenital adrenal hyperplasia (CAH) and primary adrenal insufficiency. CAH arises from enzyme deficiencies in the steroidogenesis pathway and changes in CYP11A1 activity can exacerbate the disorder by altering cortisol and aldosterone synthesis. Additionally the enzyme’s link with StAR protein suggests a possible connection to lipoid congenital adrenal hyperplasia where defects in cholesterol transport may disrupt steroid production. Understanding these relationships helps in exploring therapeutic targets for steroid-related diseases.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

A cytochrome P450 monooxygenase that catalyzes the side-chain hydroxylation and cleavage of cholesterol to pregnenolone, the precursor of most steroid hormones (PubMed : 21636783). Catalyzes three sequential oxidation reactions of cholesterol, namely the hydroxylation at C22 followed with the hydroxylation at C20 to yield 20R,22R-hydroxycholesterol that is further cleaved between C20 and C22 to yield the C21-steroid pregnenolone and 4-methylpentanal (PubMed : 21636783). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin) (PubMed : 21636783).
See full target information CYP11A1

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com